Lexicon Pharmaceuticals Ownership 2024 | Who Owns Lexicon Pharmaceuticals Now?
Institutional Ownership
113.52%
Insider Ownership
1.15%
Retail Ownership
-14.66%
Institutional Holders
119.00
Lexicon Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTAL GROUP S.A. | 71.36% | 7.50% | 175,099,384 | 57,546,100 | 48.95% | 294,166,966 | Jun 30, 2024 |
| FMR LLC | 15.77% | 0.00% | 38,687,123 | 24,793,061 | 178.44% | 64,994,367 | Jun 30, 2024 |
| BLACKROCK INC. | 4.03% | 0.00% | 9,890,153 | 2,196,876 | 28.56% | 16,615,457 | Jun 30, 2024 |
| BRAIDWELL LP | 3.38% | 0.44% | 8,294,950 | 8,294,950 | 100.00% | 13,935,516 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.13% | 0.00% | 7,675,125 | 1,273,900 | 19.90% | 12,894,211 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.38% | 0.20% | 5,846,100 | 2,304,100 | 65.05% | 9,821,448 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.68% | 0.02% | 4,121,191 | 3,536,805 | 605.22% | 6,923,601 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.32% | 0.00% | 3,250,535 | 861,398 | 36.05% | 5,461,876 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 0.97% | 0.30% | 2,382,286 | - | - | 4,002,240 | Jun 30, 2024 |
| STATE STREET CORP | 0.94% | 0.00% | 2,313,477 | 325,967 | 16.40% | 3,886,641,000 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.94% | 0.23% | 2,304,150 | 2,304,150 | 100.00% | 3,870,972 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.85% | 0.00% | 2,092,710 | 674,760 | 47.59% | 3,515,753 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.76% | 0.72% | 1,875,000 | 1,875,000 | 100.00% | 3,150,000 | Jun 30, 2024 |
| PINNACLE ASSOCIATES LTD | 0.70% | 0.05% | 1,715,831 | -31,999 | -1.83% | 2,882,596 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.55% | 0.00% | 1,359,148 | 478,025 | 54.25% | 2,283,369 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.49% | 0.00% | 1,190,448 | 691,276 | 138.48% | 1,999,953 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.41% | 0.00% | 997,528 | 130,972 | 15.11% | 1,675,847,000 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.30% | 0.00% | 738,628 | 52,210 | 7.61% | 1,240,895 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.24% | 0.00% | 597,321 | 63,137 | 11.82% | 1,003,499 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.23% | 0.02% | 571,492 | -388,658 | -40.48% | 3,236,254 | Jun 30, 2024 |
Lexicon Pharmaceuticals's largest institutional shareholder is ARTAL GROUP S.A., holding 71.36% of the company's total share outstanding, currently valued at $294.17M. The top 10 institutional shareholders own together 104.96% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTAL GROUP S.A. | 71.36% | 7.50% | 175,099,384 | 57,546,100 | 48.95% | 294,166,966 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.76% | 0.72% | 1,875,000 | 1,875,000 | 100.00% | 3,150,000 | Jun 30, 2024 |
| BRAIDWELL LP | 3.38% | 0.44% | 8,294,950 | 8,294,950 | 100.00% | 13,935,516 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 0.97% | 0.30% | 2,382,286 | - | - | 4,002,240 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.94% | 0.23% | 2,304,150 | 2,304,150 | 100.00% | 3,870,972 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.38% | 0.20% | 5,846,100 | 2,304,100 | 65.05% | 9,821,448 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.07% | 0.15% | 179,972 | -113,120 | -38.60% | 302,353 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.05% | 0.08% | 121,986 | 121,986 | 100.00% | 204,936 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.22% | 0.05% | 542,899 | 542,899 | 100.00% | 912,070 | Jun 30, 2024 |
| PINNACLE ASSOCIATES LTD | 0.70% | 0.05% | 1,715,831 | -31,999 | -1.83% | 2,882,596 | Jun 30, 2024 |
| BBR PARTNERS, LLC | 0.11% | 0.04% | 270,000 | 240,000 | 800.00% | 453,600 | Jun 30, 2024 |
| PROSPERITY FINANCIAL GROUP, INC. | 0.01% | 0.03% | 31,500 | - | - | 52,920 | Jun 30, 2024 |
| CVI HOLDINGS, LLC | 0.01% | 0.03% | 20,000 | 20,000 | 100.00% | 33,600 | Jun 30, 2024 |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 0.01% | 0.02% | 35,714 | - | - | 60,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.23% | 0.02% | 571,492 | -388,658 | -40.48% | 3,236,254 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.68% | 0.02% | 4,121,191 | 3,536,805 | 605.22% | 6,923,601 | Jun 30, 2024 |
| VERMILLION & WHITE WEALTH MANAGEMENT GROUP, LLC | 0.01% | 0.02% | 12,415 | - | - | 20,857 | Jun 30, 2024 |
| LIFESTEPS FINANCIAL, INC. | 0.00% | 0.01% | 10,000 | - | - | 16,800 | Jun 30, 2024 |
| KWB WEALTH | 0.02% | 0.01% | 40,640 | - | - | 97,536 | Jun 30, 2024 |
| COYLE FINANCIAL COUNSEL LLC | 0.01% | 0.01% | 12,500 | - | - | 30,000 | Jun 30, 2024 |
The largest Lexicon Pharmaceuticals shareholder by % of total assets is ARTAL GROUP S.A.. The company owns 175.10M shares of Lexicon Pharmaceuticals (LXRX), representing 7.50% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTAL GROUP S.A. | 71.36% | 7.50% | 175,099,384 | 57,546,100 | 48.95% | 294,166,966 | Jun 30, 2024 |
| FMR LLC | 15.77% | 0.00% | 38,687,123 | 24,793,061 | 178.44% | 64,994,367 | Jun 30, 2024 |
| BRAIDWELL LP | 3.38% | 0.44% | 8,294,950 | 8,294,950 | 100.00% | 13,935,516 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.68% | 0.02% | 4,121,191 | 3,536,805 | 605.22% | 6,923,601 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.94% | 0.23% | 2,304,150 | 2,304,150 | 100.00% | 3,870,972 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.38% | 0.20% | 5,846,100 | 2,304,100 | 65.05% | 9,821,448 | Jun 30, 2024 |
| BLACKROCK INC. | 4.03% | 0.00% | 9,890,153 | 2,196,876 | 28.56% | 16,615,457 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.76% | 0.72% | 1,875,000 | 1,875,000 | 100.00% | 3,150,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.13% | 0.00% | 7,675,125 | 1,273,900 | 19.90% | 12,894,211 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.32% | 0.00% | 3,250,535 | 861,398 | 36.05% | 5,461,876 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.49% | 0.00% | 1,190,448 | 691,276 | 138.48% | 1,999,953 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.85% | 0.00% | 2,092,710 | 674,760 | 47.59% | 3,515,753 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.22% | 0.05% | 542,899 | 542,899 | 100.00% | 912,070 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.55% | 0.00% | 1,359,148 | 478,025 | 54.25% | 2,283,369 | Jun 30, 2024 |
| STATE STREET CORP | 0.94% | 0.00% | 2,313,477 | 325,967 | 16.40% | 3,886,641,000 | Jun 30, 2024 |
| BBR PARTNERS, LLC | 0.11% | 0.04% | 270,000 | 240,000 | 800.00% | 453,600 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.15% | 0.00% | 373,431 | 217,217 | 139.05% | 627,364 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.41% | 0.00% | 997,528 | 130,972 | 15.11% | 1,675,847,000 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.05% | 0.08% | 121,986 | 121,986 | 100.00% | 204,936 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.16% | 0.00% | 401,908 | 109,902 | 37.64% | 675,206 | Jun 30, 2024 |
As of Jun 30 2024, Lexicon Pharmaceuticals's largest institutional buyer is ARTAL GROUP S.A.. The company purchased 57.55M stocks of LXRX, valued at $294.17M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -1,686,924 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -1,404,928 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.23% | 0.02% | 571,492 | -388,658 | -40.48% | 3,236,254 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -319,058 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.09% | 0.00% | 216,266 | -307,911 | -58.74% | 363,328 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -293,333 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.01% | 0.00% | 19,156 | -170,275 | -89.89% | 32,182 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.07% | 0.15% | 179,972 | -113,120 | -38.60% | 302,353 | Jun 30, 2024 |
| NATIXIS ADVISORS, L.P. | - | - | - | -86,094 | -100.00% | - | Jun 30, 2024 |
| LAZARD FRERES GESTION S.A.S. | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -45,658 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -43,591 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.01% | - | 18,607 | -40,771 | -68.66% | 31,260 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -34,433 | -100.00% | - | Jun 30, 2024 |
| PINNACLE ASSOCIATES LTD | 0.70% | 0.05% | 1,715,831 | -31,999 | -1.83% | 2,882,596 | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -29,400 | -100.00% | - | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.02% | 0.00% | 61,085 | -28,878 | -32.10% | 102,623 | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 39,437 | -25,182 | -38.97% | 66,000 | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -16,965 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.01% | - | 31,890 | -6,847 | -17.68% | 53,575 | Jun 30, 2024 |
As of Jun 30 2024, Lexicon Pharmaceuticals's biggest institutional seller is BVF INC/IL. The company sold -1.69M shares of LXRX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRAIDWELL LP | 3.38% | 0.44% | 8,294,950 | 8,294,950 | 100.00% | 13,935,516 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 0.94% | 0.23% | 2,304,150 | 2,304,150 | 100.00% | 3,870,972 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.76% | 0.72% | 1,875,000 | 1,875,000 | 100.00% | 3,150,000 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.22% | 0.05% | 542,899 | 542,899 | 100.00% | 912,070 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.05% | 0.08% | 121,986 | 121,986 | 100.00% | 204,936 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 61,770 | 61,770 | 100.00% | 103,774 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 47,183 | 47,183 | 100.00% | 79,267 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 0.01% | 0.01% | 30,000 | 30,000 | 100.00% | 50,400 | Jun 30, 2024 |
| CVI HOLDINGS, LLC | 0.01% | 0.03% | 20,000 | 20,000 | 100.00% | 33,600 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.01% | 0.00% | 18,158 | 18,158 | 100.00% | 30,505 | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | 0.01% | 0.00% | 15,120 | 15,120 | 100.00% | 25,402 | Jun 30, 2024 |
| CIBC WORLD MARKET INC. | 0.00% | - | 10,980 | 10,980 | 100.00% | 18,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 10,792 | 10,792 | 100.00% | 18,778 | Jun 30, 2024 |
| MANCHESTER CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 2,380 | 2,380 | 100.00% | 3,999 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 726 | 726 | 100.00% | 1,263 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 639 | 639 | 100.00% | 1,074 | Jun 30, 2024 |
| SJS INVESTMENT CONSULTING INC. | 0.00% | 0.00% | 400 | 400 | 100.00% | 672 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 175 | 175 | 100.00% | 294 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 155 | 155 | 100.00% | 260 | Jun 30, 2024 |
| LARSON FINANCIAL GROUP LLC | - | - | 100 | 100 | 100.00% | 168 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 75 | 75 | 100.00% | 126 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | - | - | 52 | 52 | 100.00% | 87 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | 1 | 1 | 100.00% | 2,000 | Jun 30, 2024 |
Lexicon Pharmaceuticals's largest new institutional shareholder by number of shares is BRAIDWELL LP, purchased 8.29M shares, valued at $13.94M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | - | - | - | -1,686,924 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -1,404,928 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -319,058 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -293,333 | -100.00% | - | Jun 30, 2024 |
| NATIXIS ADVISORS, L.P. | - | - | - | -86,094 | -100.00% | - | Jun 30, 2024 |
| LAZARD FRERES GESTION S.A.S. | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -45,658 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -43,591 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -34,433 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -29,400 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -16,965 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,495 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -1,200 | -100.00% | - | Jun 30, 2024 |
| AVION WEALTH | - | - | - | -407 | -100.00% | - | Jun 30, 2024 |
| IFP ADVISORS, INC | - | - | - | -150 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -21 | -100.00% | - | Jun 30, 2024 |
Lexicon Pharmaceuticals's largest sold out institutional shareholder by shares sold is BVF INC/IL, sold -1.69M shares, valued at -, as of undefined.
Lexicon Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Federated Hermes MDT Series | 0.69% | 1,694,584 | - | - | Jan 31, 2024 |
| Monteagle Funds | 0.38% | 15,600 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.17% | 250,923 | 129,212 | 106.16% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.16% | 84,532 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.07% | 1,584 | - | - | Dec 31, 2023 |
| BRIDGEWAY FUNDS INC | 0.06% | 135,500 | - | - | Mar 28, 2024 |
| FORUM FUNDS II | 0.05% | 50,162 | - | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.05% | 1,422,974 | - | - | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.04% | 542,066 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 159,542 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 14,403 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 75,766 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,087,400 | - | - | Feb 29, 2024 |
| Lattice Strategies Trust | 0.02% | 25,162 | - | - | Mar 31, 2024 |
| SSGA FUNDS | 0.02% | 7,167 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 5,522,655 | -1,386,327 | -20.07% | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 79,058 | - | - | Aug 31, 2023 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.01% | 11,697 | - | - | Mar 28, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,763 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 36,367 | - | - | Mar 31, 2020 |
| GPS Funds I | 0.01% | 34,436 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 258,446 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,228,735 | 74,578 | 6.46% | Feb 29, 2024 |
| Legg Mason ETF Investment Trust | 0.01% | 11,082 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 8,867 | 3,500 | 65.21% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 55,618 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 31,571 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 75,792 | -5,927 | -7.25% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 46,297 | 1,088 | 2.41% | Mar 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 33,448 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 43,089 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 528,068 | 39,254 | 8.03% | Feb 29, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 16,015 | - | - | Feb 29, 2024 |
| JPMORGAN TRUST II | 0.00% | 1,465,284 | - | - | Feb 29, 2024 |
| TIMOTHY PLAN | 0.00% | 5,824 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 5,400 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 623,861 | 22,182 | 3.69% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 28,969 | -8,390 | -22.46% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 4,215 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 202,626 | - | - | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 340 | - | - | Apr 30, 2021 |
| PFM Multi-Manager Series Trust | 0.00% | 500 | - | - | Dec 31, 2023 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 335,198 | -156,410 | -31.82% | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 2,624 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 31,021 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,227 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 132,690 | - | - | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 12,224 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 4,516 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 48,079 | -3,917 | -7.53% | Mar 28, 2024 |
| EQ ADVISORS TRUST | 0.00% | 385,039 | -28,751 | -6.95% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 338,021 | 113,131 | 50.31% | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 1,237,245 | 448,575 | 56.88% | Jan 31, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 70,439 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 228,057 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 3,582,439 | -40,660 | -1.12% | Mar 31, 2024 |
| Advisors' Inner Circle Fund II | 0.00% | 180,000 | - | - | Jan 31, 2024 |
| Victory Portfolios II | 0.00% | 10,585 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 409,942 | 49,373 | 13.69% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 845 | - | - | Dec 31, 2023 |
| PGIM ETF TRUST | 0.00% | 11,691 | - | - | Feb 29, 2024 |
| WisdomTree Trust | 0.00% | 353,947 | - | - | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 13,143 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 31,949 | 5,575 | 21.14% | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 31,873 | 4,281 | 15.52% | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 8,160 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 37,766 | 13,936 | 58.48% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 16,008 | 3,263 | 25.60% | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 419 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 8,796 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,560 | - | - | Mar 28, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 4,768 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 10,276 | -213 | -2.03% | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 29,980 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 408 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 7,385 | - | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 12,789 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 719 | -60 | -7.70% | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 181,299 | - | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 1,505 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 55 | - | - | Dec 31, 2023 |
| FLEXSHARES TRUST | 0.00% | 3,572 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 5,000 | - | - | Mar 31, 2024 |
| Janus Detroit Street Trust | 0.00% | 6,034 | - | - | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 2,353 | 2,353 | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 16,936 | - | - | Jan 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 120,647 | -191,109 | -61.30% | Mar 28, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 10,899 | - | - | Jan 31, 2024 |
| AMERICAN BEACON FUNDS | 0.00% | 118,334 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 76,516 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 10,496 | -42 | -0.40% | Jan 31, 2024 |
| Meeder Funds | 0.00% | 122 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,519 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 67,765 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust I | 0.00% | 151,523 | -240,087 | -61.31% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 379 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 14,828 | -13,830 | -48.26% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 35,256 | 17,326 | 96.63% | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 18,697 | - | - | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 6,799 | - | - | Jan 31, 2024 |
Lexicon Pharmaceuticals's largest mutual fund holder by % of total assets is "Federated Hermes MDT Series", owning 1.69M shares, compromising 0.69% of its total assets.
Lexicon Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 119 | -2.46% |
| 31 Mar, 24 | 122 | 10.91% |
| 31 Dec, 23 | 110 | -3.51% |
| 30 Sep, 23 | 114 | -10.24% |
| 30 Jun, 23 | 127 | 19.81% |
| 31 Mar, 23 | 106 | - |
| 31 Dec, 22 | 106 | 7.07% |
| 30 Sep, 22 | 99 | 11.24% |
| 30 Jun, 22 | 89 | -13.59% |
| 31 Mar, 22 | 103 | -11.97% |
| 31 Dec, 21 | 117 | 14.71% |
| 30 Sep, 21 | 102 | -11.30% |
| 30 Jun, 21 | 115 | 3.60% |
| 31 Mar, 21 | 111 | - |
| 31 Dec, 20 | 111 | 18.09% |
| 30 Sep, 20 | 94 | -14.55% |
| 30 Jun, 20 | 110 | -4.35% |
| 31 Mar, 20 | 115 | -6.50% |
| 31 Dec, 19 | 123 | 10.81% |
| 30 Sep, 19 | 111 | -6.72% |
| 30 Jun, 19 | 119 | -8.46% |
| 31 Mar, 19 | 130 | 1.56% |
| 31 Dec, 18 | 128 | - |
| 30 Sep, 18 | 128 | -2.29% |
| 30 Jun, 18 | 131 | - |
| 31 Mar, 18 | 131 | -3.68% |
| 31 Dec, 17 | 136 | -9.33% |
| 30 Sep, 17 | 150 | 4.17% |
| 30 Jun, 17 | 144 | -1.37% |
| 31 Mar, 17 | 146 | -3.95% |
| 31 Dec, 16 | 152 | 0.66% |
| 30 Sep, 16 | 151 | 4.86% |
| 30 Jun, 16 | 144 | 6.67% |
| 31 Mar, 16 | 135 | 8.00% |
| 31 Dec, 15 | 125 | 15.74% |
| 30 Sep, 15 | 108 | 25.58% |
| 30 Jun, 15 | 86 | - |
As of 30 Jun 24, 119 institutions are holding Lexicon Pharmaceuticals's shares, representing a decrease of -2.46% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 278,556,915 | 61.21% |
| 31 Mar, 24 | 172,789,084 | -5.49% |
| 31 Dec, 23 | 182,824,838 | -3.14% |
| 30 Sep, 23 | 188,754,252 | -1.34% |
| 30 Jun, 23 | 191,323,354 | 31.42% |
| 31 Mar, 23 | 145,586,770 | -0.87% |
| 31 Dec, 22 | 146,860,614 | -1.34% |
| 30 Sep, 22 | 148,848,418 | 25.31% |
| 30 Jun, 22 | 118,780,804 | -1.13% |
| 31 Mar, 22 | 120,137,874 | -1.16% |
| 31 Dec, 21 | 121,547,007 | 0.37% |
| 30 Sep, 21 | 121,097,673 | 2.90% |
| 30 Jun, 21 | 117,679,424 | -2.91% |
| 31 Mar, 21 | 121,202,374 | -0.67% |
| 31 Dec, 20 | 122,017,369 | 17.04% |
| 30 Sep, 20 | 104,253,690 | -2.75% |
| 30 Jun, 20 | 107,198,391 | 2.27% |
| 31 Mar, 20 | 104,818,695 | -2.19% |
| 31 Dec, 19 | 107,164,213 | 4.64% |
| 30 Sep, 19 | 102,410,003 | -3.13% |
| 30 Jun, 19 | 105,716,590 | 1.06% |
| 31 Mar, 19 | 104,603,954 | -0.71% |
| 31 Dec, 18 | 105,353,088 | -1.97% |
| 30 Sep, 18 | 107,472,461 | -1.23% |
| 30 Jun, 18 | 108,807,742 | -0.86% |
| 31 Mar, 18 | 109,749,777 | -1.53% |
| 31 Dec, 17 | 111,460,269 | -2.90% |
| 30 Sep, 17 | 114,785,240 | -0.07% |
| 30 Jun, 17 | 114,864,097 | 0.58% |
| 31 Mar, 17 | 114,197,330 | 3.26% |
| 31 Dec, 16 | 110,597,007 | 0.11% |
| 30 Sep, 16 | 110,477,262 | -0.23% |
| 30 Jun, 16 | 110,728,727 | -0.05% |
| 31 Mar, 16 | 110,779,768 | 1.37% |
| 31 Dec, 15 | 109,284,091 | 3.23% |
| 30 Sep, 15 | 105,861,179 | 9.36% |
| 30 Jun, 15 | 96,802,935 | - |
Lexicon Pharmaceuticals (LXRX) has 278.56M shares outstanding as of 30 Jun 24, up 61.21% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 113.52% | 1.86% |
| 31 Mar, 24 | 78.14% | 1.40% |
| 31 Dec, 23 | 74.65% | 0.88% |
| 30 Sep, 23 | 92.17% | 0.90% |
| 30 Jun, 23 | 101.22% | 1.71% |
| 31 Mar, 23 | 77.02% | 1.27% |
| 31 Dec, 22 | 77.82% | 1.07% |
| 30 Sep, 22 | 85.10% | 1.35% |
| 30 Jun, 22 | 79.39% | 1.22% |
| 31 Mar, 22 | 80.55% | 1.21% |
| 31 Dec, 21 | 81.63% | 1.18% |
| 30 Sep, 21 | 83.05% | 1.25% |
| 30 Jun, 21 | 81.47% | 1.14% |
| 31 Mar, 21 | 84.53% | 0.85% |
| 31 Dec, 20 | 99.72% | 1.06% |
| 30 Sep, 20 | 97.15% | 0.97% |
| 30 Jun, 20 | 100.12% | 1.03% |
| 31 Mar, 20 | 98.39% | 0.97% |
| 31 Dec, 19 | 100.84% | 1.09% |
| 30 Sep, 19 | 96.37% | 0.97% |
| 30 Jun, 19 | 99.48% | 1.02% |
| 31 Mar, 19 | 98.63% | 1.00% |
| 31 Dec, 18 | 99.46% | 0.97% |
| 30 Sep, 18 | 101.50% | 0.96% |
| 30 Jun, 18 | 102.80% | 0.95% |
| 31 Mar, 18 | 103.86% | 0.93% |
| 31 Dec, 17 | 105.91% | 0.90% |
| 30 Sep, 17 | 108.72% | 0.91% |
| 30 Jun, 17 | 109.08% | 0.91% |
| 31 Mar, 17 | 109.32% | 0.97% |
| 31 Dec, 16 | 106.29% | 0.94% |
| 30 Sep, 16 | 106.35% | 0.94% |
| 30 Jun, 16 | 106.64% | 0.93% |
| 31 Mar, 16 | 106.85% | 0.96% |
| 31 Dec, 15 | 105.46% | 1.01% |
| 30 Sep, 15 | 102.17% | 1.17% |
| 30 Jun, 15 | 93.43% | - |
As of 30 Jun 24, Lexicon Pharmaceuticals is held by 113.52% institutional shareholders, representing a 1.86% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 67 | 1.52% |
| 31 Mar, 24 | 66 | 17.86% |
| 31 Dec, 23 | 56 | 1.82% |
| 30 Sep, 23 | 55 | -31.25% |
| 30 Jun, 23 | 80 | 50.94% |
| 31 Mar, 23 | 53 | 3.92% |
| 31 Dec, 22 | 51 | -13.56% |
| 30 Sep, 22 | 59 | 63.89% |
| 30 Jun, 22 | 36 | -18.18% |
| 31 Mar, 22 | 44 | -27.87% |
| 31 Dec, 21 | 61 | 52.50% |
| 30 Sep, 21 | 40 | -35.48% |
| 30 Jun, 21 | 62 | 6.90% |
| 31 Mar, 21 | 58 | 5.45% |
| 31 Dec, 20 | 55 | 44.74% |
| 30 Sep, 20 | 38 | -34.48% |
| 30 Jun, 20 | 58 | 3.57% |
| 31 Mar, 20 | 56 | - |
| 31 Dec, 19 | 56 | 36.59% |
| 30 Sep, 19 | 41 | 7.89% |
| 30 Jun, 19 | 38 | -34.48% |
| 31 Mar, 19 | 58 | 31.82% |
| 31 Dec, 18 | 44 | -2.22% |
| 30 Sep, 18 | 45 | -25.00% |
| 30 Jun, 18 | 60 | 15.38% |
| 31 Mar, 18 | 52 | -8.77% |
| 31 Dec, 17 | 57 | -16.18% |
| 30 Sep, 17 | 68 | 9.68% |
| 30 Jun, 17 | 62 | -13.89% |
| 31 Mar, 17 | 72 | -5.26% |
| 31 Dec, 16 | 76 | -7.32% |
| 30 Sep, 16 | 82 | 3.80% |
| 30 Jun, 16 | 79 | 6.76% |
| 31 Mar, 16 | 74 | 15.63% |
| 31 Dec, 15 | 64 | -4.48% |
| 30 Sep, 15 | 67 | -22.09% |
| 30 Jun, 15 | 86 | - |
67 institutional shareholders have increased their position in LXRX stock as of 30 Jun 24 compared to 66 in the previous quarter (a 1.52% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -27.59% |
| 31 Mar, 24 | 29 | 26.09% |
| 31 Dec, 23 | 23 | -20.69% |
| 30 Sep, 23 | 29 | 31.82% |
| 30 Jun, 23 | 22 | -31.25% |
| 31 Mar, 23 | 32 | 6.67% |
| 31 Dec, 22 | 30 | 42.86% |
| 30 Sep, 22 | 21 | -27.59% |
| 30 Jun, 22 | 29 | -19.44% |
| 31 Mar, 22 | 36 | 20.00% |
| 31 Dec, 21 | 30 | -14.29% |
| 30 Sep, 21 | 35 | 20.69% |
| 30 Jun, 21 | 29 | -3.33% |
| 31 Mar, 21 | 30 | -9.09% |
| 31 Dec, 20 | 33 | 26.92% |
| 30 Sep, 20 | 26 | 4.00% |
| 30 Jun, 20 | 25 | -10.71% |
| 31 Mar, 20 | 28 | -17.65% |
| 31 Dec, 19 | 34 | 21.43% |
| 30 Sep, 19 | 28 | -24.32% |
| 30 Jun, 19 | 37 | 23.33% |
| 31 Mar, 19 | 30 | -31.82% |
| 31 Dec, 18 | 44 | 2.33% |
| 30 Sep, 18 | 43 | 22.86% |
| 30 Jun, 18 | 35 | 2.94% |
| 31 Mar, 18 | 34 | -15.00% |
| 31 Dec, 17 | 40 | 25.00% |
| 30 Sep, 17 | 32 | -33.33% |
| 30 Jun, 17 | 48 | 11.63% |
| 31 Mar, 17 | 43 | 13.16% |
| 31 Dec, 16 | 38 | -11.63% |
| 30 Sep, 16 | 43 | 16.22% |
| 30 Jun, 16 | 37 | 15.63% |
| 31 Mar, 16 | 32 | -8.57% |
| 31 Dec, 15 | 35 | 66.67% |
| 30 Sep, 15 | 21 | - |
| 30 Jun, 15 | - | - |
21 institutional shareholders have reduced their position in LXRX stock as of 30 Jun 24 compared to 29 in the previous quarter (a -27.59% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 119 | -2.46% | 278,556,915 | 61.21% | 113.52% | 1.86% | 67 | 1.52% | 21 | -27.59% |
| 31 Mar, 24 | 122 | 10.91% | 172,789,084 | -5.49% | 78.14% | 1.40% | 66 | 17.86% | 29 | 26.09% |
| 31 Dec, 23 | 110 | -3.51% | 182,824,838 | -3.14% | 74.65% | 0.88% | 56 | 1.82% | 23 | -20.69% |
| 30 Sep, 23 | 114 | -10.24% | 188,754,252 | -1.34% | 92.17% | 0.90% | 55 | -31.25% | 29 | 31.82% |
| 30 Jun, 23 | 127 | 19.81% | 191,323,354 | 31.42% | 101.22% | 1.71% | 80 | 50.94% | 22 | -31.25% |
| 31 Mar, 23 | 106 | - | 145,586,770 | -0.87% | 77.02% | 1.27% | 53 | 3.92% | 32 | 6.67% |
| 31 Dec, 22 | 106 | 7.07% | 146,860,614 | -1.34% | 77.82% | 1.07% | 51 | -13.56% | 30 | 42.86% |
| 30 Sep, 22 | 99 | 11.24% | 148,848,418 | 25.31% | 85.10% | 1.35% | 59 | 63.89% | 21 | -27.59% |
| 30 Jun, 22 | 89 | -13.59% | 118,780,804 | -1.13% | 79.39% | 1.22% | 36 | -18.18% | 29 | -19.44% |
| 31 Mar, 22 | 103 | -11.97% | 120,137,874 | -1.16% | 80.55% | 1.21% | 44 | -27.87% | 36 | 20.00% |
| 31 Dec, 21 | 117 | 14.71% | 121,547,007 | 0.37% | 81.63% | 1.18% | 61 | 52.50% | 30 | -14.29% |
| 30 Sep, 21 | 102 | -11.30% | 121,097,673 | 2.90% | 83.05% | 1.25% | 40 | -35.48% | 35 | 20.69% |
| 30 Jun, 21 | 115 | 3.60% | 117,679,424 | -2.91% | 81.47% | 1.14% | 62 | 6.90% | 29 | -3.33% |
| 31 Mar, 21 | 111 | - | 121,202,374 | -0.67% | 84.53% | 0.85% | 58 | 5.45% | 30 | -9.09% |
| 31 Dec, 20 | 111 | 18.09% | 122,017,369 | 17.04% | 99.72% | 1.06% | 55 | 44.74% | 33 | 26.92% |
| 30 Sep, 20 | 94 | -14.55% | 104,253,690 | -2.75% | 97.15% | 0.97% | 38 | -34.48% | 26 | 4.00% |
| 30 Jun, 20 | 110 | -4.35% | 107,198,391 | 2.27% | 100.12% | 1.03% | 58 | 3.57% | 25 | -10.71% |
| 31 Mar, 20 | 115 | -6.50% | 104,818,695 | -2.19% | 98.39% | 0.97% | 56 | - | 28 | -17.65% |
| 31 Dec, 19 | 123 | 10.81% | 107,164,213 | 4.64% | 100.84% | 1.09% | 56 | 36.59% | 34 | 21.43% |
| 30 Sep, 19 | 111 | -6.72% | 102,410,003 | -3.13% | 96.37% | 0.97% | 41 | 7.89% | 28 | -24.32% |
| 30 Jun, 19 | 119 | -8.46% | 105,716,590 | 1.06% | 99.48% | 1.02% | 38 | -34.48% | 37 | 23.33% |
| 31 Mar, 19 | 130 | 1.56% | 104,603,954 | -0.71% | 98.63% | 1.00% | 58 | 31.82% | 30 | -31.82% |
| 31 Dec, 18 | 128 | - | 105,353,088 | -1.97% | 99.46% | 0.97% | 44 | -2.22% | 44 | 2.33% |
| 30 Sep, 18 | 128 | -2.29% | 107,472,461 | -1.23% | 101.50% | 0.96% | 45 | -25.00% | 43 | 22.86% |
| 30 Jun, 18 | 131 | - | 108,807,742 | -0.86% | 102.80% | 0.95% | 60 | 15.38% | 35 | 2.94% |
| 31 Mar, 18 | 131 | -3.68% | 109,749,777 | -1.53% | 103.86% | 0.93% | 52 | -8.77% | 34 | -15.00% |
| 31 Dec, 17 | 136 | -9.33% | 111,460,269 | -2.90% | 105.91% | 0.90% | 57 | -16.18% | 40 | 25.00% |
| 30 Sep, 17 | 150 | 4.17% | 114,785,240 | -0.07% | 108.72% | 0.91% | 68 | 9.68% | 32 | -33.33% |
| 30 Jun, 17 | 144 | -1.37% | 114,864,097 | 0.58% | 109.08% | 0.91% | 62 | -13.89% | 48 | 11.63% |
| 31 Mar, 17 | 146 | -3.95% | 114,197,330 | 3.26% | 109.32% | 0.97% | 72 | -5.26% | 43 | 13.16% |
| 31 Dec, 16 | 152 | 0.66% | 110,597,007 | 0.11% | 106.29% | 0.94% | 76 | -7.32% | 38 | -11.63% |
| 30 Sep, 16 | 151 | 4.86% | 110,477,262 | -0.23% | 106.35% | 0.94% | 82 | 3.80% | 43 | 16.22% |
| 30 Jun, 16 | 144 | 6.67% | 110,728,727 | -0.05% | 106.64% | 0.93% | 79 | 6.76% | 37 | 15.63% |
| 31 Mar, 16 | 135 | 8.00% | 110,779,768 | 1.37% | 106.85% | 0.96% | 74 | 15.63% | 32 | -8.57% |
| 31 Dec, 15 | 125 | 15.74% | 109,284,091 | 3.23% | 105.46% | 1.01% | 64 | -4.48% | 35 | 66.67% |
| 30 Sep, 15 | 108 | 25.58% | 105,861,179 | 9.36% | 102.17% | 1.17% | 67 | -22.09% | 21 | - |
| 30 Jun, 15 | 86 | - | 96,802,935 | - | 93.43% | - | 86 | - | - | - |
Lexicon Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Lexicon Pharmaceuticals's stock was made by Artal International S.C.A. on May 14 2024, selling 1,150,922 shares at - per share (valued at -).
Lexicon Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 3 | - | - |
| Q2 2024 | 22 | 7 | 314.29% |
| Q1 2024 | 41 | 30 | 136.67% |
| Q4 2023 | 6 | - | - |
| Q3 2023 | 3 | - | - |
| Q2 2023 | 32 | 8 | 400.00% |
| Q1 2023 | 41 | 32 | 128.13% |
| Q3 2022 | 9 | - | - |
| Q2 2022 | 18 | 7 | 257.14% |
| Q1 2022 | 40 | 27 | 148.15% |
| Q4 2021 | - | 19 | - |
| Q3 2021 | 1 | 7 | 14.29% |
| Q2 2021 | 24 | 8 | 300.00% |
| Q1 2021 | 37 | 27 | 137.04% |
| Q4 2020 | 2 | 2 | 100.00% |
| Q2 2020 | 31 | 15 | 206.67% |
| Q1 2020 | 47 | 38 | 123.68% |
| Q4 2019 | - | 13 | - |
| Q3 2019 | 124 | - | - |
| Q2 2019 | 16 | - | - |
3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Lexicon Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 5 | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 8 | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | 9 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 2 | - |
| Q4 2020 | 2 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | 124 | - | - |
| Q2 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Lexicon Pharmaceuticals's stocks.
Lexicon Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| CWBR | CohBar, Inc. |
| MREO | Mereo BioPharma Group plc |
| DAWN | Day One Biopharmaceuticals, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| BLRX | BioLineRx Ltd. |
| MCRB | Seres Therapeutics, Inc. |
| ARDX | Ardelyx, Inc. |
| AVRO | AVROBIO, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| IBRX | ImmunityBio, Inc. |
| EFTR | eFFECTOR Therapeutics, Inc. |
| OCEA | Ocean Biomedical, Inc. |
| HEPA | Hepion Pharmaceuticals, Inc. |
| ELEV | Elevation Oncology, Inc. |
| ENVB | Enveric Biosciences, Inc. |
| GRTX | Galera Therapeutics, Inc. |
LXRX Ownership FAQ
Who Owns Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals is owned by institutional shareholders (113.52%), insiders (1.15%), and public (-14.66%). The largest institutional shareholder of Lexicon Pharmaceuticals is ARTAL GROUP S.A. (71.36% of total shares) and the top mutual fund owner is Federated Hermes MDT Series (0.69% of total shares).
Who are the major institutional shareholders of Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals's major institutional shareholders are ARTAL GROUP S.A., FMR LLC, BLACKROCK INC., BRAIDWELL LP, and VANGUARD GROUP INC. The top five shareholders own together 97.66% of the company's share outstanding.
How many Lexicon Pharmaceuticals shareholders are there?
As of Jun 2024, there are 119 institutional shareholders of Lexicon Pharmaceuticals.
What percentage of Lexicon Pharmaceuticals is owned by ARTAL GROUP S.A?
ARTAL GROUP S.A owns 175.1M shares of Lexicon Pharmaceuticals, representing 71.36% of the company's total shares outstanding, valued at $294.17M (as of Jun 2024).
What percentage of Lexicon Pharmaceuticals is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 38.69M shares of Lexicon Pharmaceuticals (LXRX), compromising 15.77% of the company, valued at $64.99M.
What percentage of Lexicon Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Lexicon Pharmaceuticals. The company owns 9.89M of the company's shares outstanding (worth $16.62M).